Value of autophagy-related gene 5 (ATG5) expression as a prognostic marker in adults with newly diagnosed acute lymphoblastic leukaemia (ALL)
- 18.06.2021
- original report
Erschienen in:
- Verfasst von
- Rasha I. Ibrahim
- Haydi S. Mohamed
- Mary G. Nagib
- Hebatullah M. Fares
- Alia M. Saeed
- Erschienen in
- memo - Magazine of European Medical Oncology | Ausgabe 4/2021
Summary
Background
Autophagy is considered a pivotal cellular mechanism to cope with stress and maintain homeostasis. It is frequently dysregulated in various types of cancers with some exhibiting excessive and others having reduced autophagy levels.
Aim
The goal was to determine autophagy status in newly diagnosed adult acute lymphoblastic leukaemia (ALL) patients compared to age- and sex-matched controls. Moreover, its prognostic impact on disease characteristics and response to treatment were evaluated.
Patients and methods
Thirty-five newly diagnosed adult ALL patients were recruited and age and sex matched to 15 healthy control subjects. ATG5 expression was measured on diagnosis using real-time quantitative polymerase chain reaction (qPCR). Cases have been followed up for one year after enrolment into the study.
Results
Mean ATG5 expression in ALL was twice that of controls, which is a high statistically significant difference (2.15 ± 2.2 vs 1.09 ± 0.47, P value = 0.01). High ATG5 expression has been significantly associated with B‑ALL phenotype, lower haemoglobin and lower platelet counts. Of note, the higher expressor group had higher bone marrow and peripheral blood blast percentages and greater likelihood to develop chemoresistance to frontline agents, but this was not statistically significant. Further studies with larger numbers of patients are needed to examine the relationship between autophagy activation and therapeutic outcome in ALL.
Anzeige
- Titel
- Value of autophagy-related gene 5 (ATG5) expression as a prognostic marker in adults with newly diagnosed acute lymphoblastic leukaemia (ALL)
- Verfasst von
-
Rasha I. Ibrahim
Haydi S. Mohamed
Mary G. Nagib
Hebatullah M. Fares
Alia M. Saeed
- Publikationsdatum
- 18.06.2021
- Verlag
- Springer Vienna
- Erschienen in
-
memo - Magazine of European Medical Oncology / Ausgabe 4/2021
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076 - DOI
- https://doi.org/10.1007/s12254-021-00715-3
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.